EPIX ESSA Pharma Inc: Accounting Value per Share

Public company logo of ESSA Pharma Inc. (EPIX)

How sustainable is the financial position of ESSA Pharma Inc. (EPIX)? This chart provided by GURU.Markets shows that the book value per share currently stands at 2.46. Stability is underpinned by a lack of debt and a liquid reserve. Growth is driven by mazofotenan trials and interest from corporate behemoths. The development of treatments for resistant forms of prostate cancer confirms an active business expansion stage.

ESSA Pharma Inc (EPIX) - Accounting Value per Share from 07/04/2022 to 10/25/2025
Manufactured product of ESSA Pharma, Inc.

For ESSA Pharma Inc. (EPIX), the development of prostate cancer therapy is associated with a high cash burn, making the calculated book value per share a key indicator of the business's financial cushion. This metric reflects the portion of net assets attributable to a single share, allowing for an assessment of the company's real intrinsic value regardless of market volatility and confirming the capital's resilience to inflation.